% | $
Quotes you view appear here for quick access.

Anthera Pharmaceuticals, Inc. Message Board

  • smelky_kid smelky_kid May 3, 2013 1:44 PM Flag

    Instead of selling off the company for its tax losses and cash,

    Paul Truex has decided to continue the destruction of shareholder value by continuing the B-mod program and diluting shareholders by over 200%. His sole purpose is to continue paying his salary and those of his management team. The market spoke last June when the phase 2 B results were announced. This drug failed. The industry spoke when, after 11 months, not one company came forward to partner this drug. But rather than doing the right thing for shareholders, and liquidating at 2 bucks a share, he chose to dilute and run a costly trial on his own. And now, you shareholders are left with a 53 cent stock. Mr. Truex will still retain his 700K salary, while loyal shareholders foot the bill. Enjoy your company, people....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.22+0.03(+0.94%)Aug 23 4:00 PMEDT